Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer

Tamoxifen treatment for breast cancer may induce ovarian cysts and supraphysiological levels of serum estrogen. We report successful management with luteinizing hormone-releasing hormone (LHRH) agonist of ovarian hyperstimulation induced by tamoxifen. A 49-year-old woman was operated on for invasive...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Case Rep Obstet Gynecol
Auteurs principaux: Kojima, Nobue, Yamasaki, Yui, Koh, Houu, Miyashita, Masaru, Morita, Hiroki
Format: Artigo
Langue:Inglês
Publié: Hindawi 2018
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827888/
https://ncbi.nlm.nih.gov/pubmed/29607235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4931852
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires